4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0001140361-24-033600
Chief Legal Officer gave up 558 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Mary Chief Legal Officer | 2024-07-17 | Shares withheld for taxes | −558 | $7.69 | $4,291 | 39,151 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…